Israel Englander Nevro Corp Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Nevro Corp stock. As of the latest transaction made, Millennium Management LLC holds 956,542 shares of NVRO stock, worth $5.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

956,542

Previous 787,969 21.39%

Holding current value

$5.53 Million

Previous $11.4 Million 29.21%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$7.96 - $13.59 $1.34 Million - $2.29 Million	168,573 Added 21.39%	956,542 $8.05 Million
Q1 2024 May 15, 2024	SELL	$13.56 - $20.78 $1.11 Million - $1.71 Million	-82,111 Reduced 9.44%	787,969 $11.4 Million
Q4 2023 Feb 14, 2024	BUY	$14.18 - $22.31 $11.3 Million - $17.8 Million	799,486 Added 1132.51%	870,080 $18.7 Million
Q2 2023 Aug 14, 2023	SELL	$22.62 - $39.32 $12.9 Million - $22.3 Million	-568,380 Reduced 88.95%	70,594 $1.79 Million
Q1 2023 May 15, 2023	SELL	$30.17 - $41.11 $8.49 Million - $11.6 Million	-281,474 Reduced 30.58%	638,974 $23.1 Million
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $23.3 Million - $31.6 Million	638,718 Added 226.71%	920,448 $36.5 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $11.5 Million - $14.9 Million	281,730 New	281,730 $13.1 Million
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $3.5 Million - $6.65 Million	-85,674 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$59.95 - $92.06 $248,252 - $381,220	-4,141 Reduced 4.61%	85,674 $6.2 Million
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $3.26 Million - $4.88 Million	-40,265 Reduced 30.95%	89,815 $7.28 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $11.2 Million - $18.2 Million	109,477 Added 531.36%	130,080 $15.1 Million
Q2 2021 Aug 16, 2021	SELL	$141.6 - $179.06 $390,816 - $494,205	-2,760 Reduced 11.81%	20,603 $3.42 Million
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $6.54 Million - $8.97 Million	-49,228 Reduced 67.82%	23,363 $3.26 Million
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $24.2 Million - $32.3 Million	-175,486 Reduced 70.74%	72,591 $12.6 Million
Q3 2020 Nov 16, 2020	BUY	$114.09 - $145.51 $15.6 Million - $19.9 Million	136,750 Added 122.84%	248,077 $34.6 Million
Q2 2020 Aug 14, 2020	BUY	$89.45 - $129.85 $9.39 Million - $13.6 Million	104,986 Added 1655.67%	111,327 $13.3 Million
Q1 2020 May 14, 2020	SELL	$70.23 - $144.31 $12.6 Million - $26 Million	-179,832 Reduced 96.59%	6,341 $634,000
Q4 2019 Feb 14, 2020	BUY	$76.41 - $117.54 $9.23 Million - $14.2 Million	120,793 Added 184.76%	186,173 $21.9 Million
Q3 2019 Nov 14, 2019	SELL	$61.52 - $91.1 $7.58 Million - $11.2 Million	-123,248 Reduced 65.34%	65,380 $5.62 Million
Q2 2019 Aug 15, 2019	SELL	$58.04 - $66.99 $56.7 Million - $65.5 Million	-977,386 Reduced 83.82%	188,628 $12.2 Million
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $3.2 Million - $3.69 Million	55,102 Added 4.96%	1,166,014 $20.1 Million
Q1 2019 May 14, 2019	SELL	$35.52 - $62.62 $1.07 Million - $1.89 Million	-30,167 Reduced 2.64%	1,110,912 $69.4 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $13.7 Million - $21.7 Million	385,297 Added 50.98%	1,141,079 $44.4 Million
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $33.4 Million - $57 Million	755,782 New	755,782 $43.1 Million
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $42.3 Million - $54.1 Million	-584,529 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $37.5 Million - $47.8 Million	539,948 Added 1211.16%	584,529 $50.7 Million
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $49.8 Million - $70.5 Million	-755,779 Reduced 94.43%	44,581 $3.08 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $64.7 Million - $72.9 Million	800,360	800,360 $72.7 Million

Others Institutions Holding NVRO

# of Institutions

161

Shares Held

37.9M

Call Options Held

44K

Put Options Held

1.69M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $205M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account